A new therapy for people with eosinophilic esophagitis may begin a late-stage trial for treating the disorder in children. The treatment would require a monthly infusion.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||